Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0369820090390050373
Jorunal of Korean Pharmaceutical Sciences
2009 Volume.39 No. 5 p.373 ~ p.379
Pharmacokinetic-Pharmacodynamic Modeling of a Direct Thrombin Inhibitor, Argatroban, in Rats
Park Eun-Hye

Shin Beom-Soo
Lee Mann-Hyung
Yoo Sun-Dong
Abstract
This study was conducted to develop a pharmacokinetic-pharmacodynamic (PK/PD) model of a direct thrombin inhibitor, argatroban to predict the concentration-effect profiles in rats. Argatroban was i.v. injected to rats at 0. 2, 0.8 and 3.2 mg/kg doses (n = 4-5 per dose), and plasma drug levels were determined by a validated LC/MS/MS assay. The pharmacokinetics of argatroban was linear over the i.v. dose range studied. The thrombin time (TT) and the activated partial thromboplastin time (aPTT) were measured in rat plasma and they were found to linearly increase with increasing the dose. A 2-compartment pharmacokinetic model linked with an indirect response pharmacodynamic model was successfully utilized to evaluate the drug concentration-response relationship.
KEYWORD
Argatroban, Pharmacokinetics, Pharmacodynamics, Thrombin time, Activated partial thromboplastin time
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)